Interés Humano

Avances con límites en los tratamientos contra la covid–19

Más de dos años después del inicio de la pandemia, existen varios tratamientos contra esta enfermedad, aunque el uso de estas píldoras e inyecciones se enfrenta a varios límites

(FILES) This file handout photo provided to AFP on November 16, 2021 courtesy of Pfizer shows the making of its experimental Covid-19 antiviral pills inside his laboratory in Freiburg, Germany. - Pfizer said today that it will sell 10 million Covid-19 treatment courses for�Covid-19 to the US government for $5.3 billion, pending approval from regulators. The pharmaceutical giant asked the US Food and Drug Administration on November 16, 2021 for emergency use authorization for its Paxlovid pill which has been shown to cut hospitalization or death by nearly 90 percent among newly-infected high risk patients. (Photo by Handout / Pfizer / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / Pfizer " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS
(FILES) This file handout photo provided to AFP on November 16, 2021 courtesy of Pfizer shows the making of its experimental Covid-19 antiviral pills inside his laboratory in Freiburg, Germany. - Pfizer said today that it will sell 10 million Covid-19 treatment courses for�Covid-19 to the US government for $5.3 billion, pending approval from regulators. The pharmaceutical giant asked the US Food and Drug Administration on November 16, 2021 for emergency use authorization for its Paxlovid pill which has been shown to cut hospitalization or death by nearly 90 percent among newly-infected high risk patients. (Photo by Handout / Pfizer / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / Pfizer " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS HANDOUT
‌
‌

‌

‌
‌

‌

‌